Intragranulomatous necrosis in lungs of mice infected by aerosol with Mycobacterium tuberculosis is related to bacterial load rather than to any one cytokine or T cell type-Reference-Cited by-同舟云学术

Intragranulomatous necrosis in lungs of mice infected by aerosol with Mycobacterium tuberculosis is related to bacterial load rather than to any one cytokine or T cell type

Published:2006-03 Issue:3 Volume:8 Page:628-636
ISSN:1286-4579
Container-title:Microbes and Infection
language:en
Short-container-title:Microbes and Infection

Author:

Gil Olga,Guirado Evelyn,Gordillo Sergi,Díaz Jorge,Tapia Gustavo,Vilaplana Cristina,Ariza Aurelio,Ausina Vicenç,Cardona Pere-Joan

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Microbiology

Reference42 articles.

1. The Koch phenomenon and delayed hypersensitivity: 1891–1991;Bothamley;Tubercle,1991

2. Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis;Dannenberg;Immunol. Today,1991

3. Phenomenon of Local Tissue Reactivity and its Immunological, Pathological and Clinical Significance;Shwartzman,1937

4. A model for the investigation of factors influencing haemorrhagic necrosis mediated by tumour necrosis factor in tissue sites primed with mycobacterial antigen preparations;al Attiyah;Clin. Exp. Immunol.,1992

5. Cytokines and the Koch phenomenon;Rook;Tubercle,1991

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of lung damage in tuberculosis: implications for chronic obstructive pulmonary disease;Frontiers in Cellular and Infection Microbiology;2023-06-21

2. Protective Effect of Intestinal Helminthiasis Against Tuberculosis Progression Is Abrogated by Intermittent Food Deprivation;Frontiers in Immunology;2021-04-14

3. Vγ9Vδ2 T Cells: Can We Re-Purpose a Potent Anti-Infection Mechanism for Cancer Therapy?;Cells;2020-03-30

4. Influence of Gut Microbiota on Progression to Tuberculosis Generated by High Fat Diet-Induced Obesity in C3HeB/FeJ Mice;Frontiers in Immunology;2019-10-18

5. Does the Development of Vaccines Advance Solutions for Tuberculosis?;Current Molecular Pharmacology;2019-04-11